Augustine Lawlor insider trades

Open-market stock purchases and sales by Augustine Lawlor, Chief Operating Officer at Leap Therapeutics, Inc, from SEC Form 4 filings since Jan 11, 2010.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • LPTX Leap Therapeutics, Inc: 1 buy, last Mar 28, 2025
  • CBIO Catalyst Biosciences, Inc: 1 sale, last Aug 31, 2023
  • CSII Cardiovascular Systems Inc: 1 sale, last Apr 27, 2023
  • GBIM Globeimmune Inc: 16 sales, last Mar 18, 2016
  • HGSI Human Genome Sciences Inc: other filings, last Jul 30, 2012

Get free alerts when Augustine Lawlor files a new trade →